An Open-Label Study Evaluating Brexanolone in Adults With Tinnitus
Clinical trial NCT05645432 · COMPLETED
Trial details
- NCT number
- NCT05645432
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-10
- Primary completion
- 2023-11-21
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.